The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2020
Filed:
Mar. 31, 2017
Applicants:
Ucb Biopharma Srl, Brussels, BE;
Sanofi, Paris, FR;
Inventors:
Michael Louis Robert Deligny, Brussels, BE;
Jag Paul Heer, Slough Berkshire, GB;
Assignees:
UCB Biopharma SRL, Brussels, BE;
Sanofi, Paris, FR;
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 519/00 (2006.01); C07D 487/18 (2006.01); C07D 487/22 (2006.01); A61P 25/28 (2006.01); A61P 37/04 (2006.01); A61P 9/00 (2006.01); A61P 3/10 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); C07D 487/04 (2013.01); C07D 487/18 (2013.01); C07D 487/22 (2013.01); A61P 3/10 (2018.01); A61P 9/00 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01);
Abstract
A series of substituted fused pentacyclic benzimidazole derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.